Ocular Therapeutix, Inc.OCULNASDAQ
LOADING
|||
Switch Symbol:
Revenue Growth Under Pressure
Trending lower, below historical average, modest growth trend.
Left:
||||
Year-over-year revenue growth rate
Latest
8.06%
↓ 51% below average
Average (39q)
16.43%
Historical baseline
Range
High:274.51%
Low:-39.86%
CAGR
+4.2%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 8.06% |
| Q2 2025 | 25.81% |
| Q1 2025 | -37.37% |
| Q4 2024 | 10.74% |
| Q3 2024 | -6.18% |
| Q2 2024 | 11.28% |
| Q1 2024 | -0.18% |
| Q4 2023 | -1.86% |
| Q3 2023 | -0.69% |
| Q2 2023 | 13.55% |
| Q1 2023 | -4.98% |
| Q4 2022 | 17.63% |
| Q3 2022 | -2.45% |
| Q2 2022 | -6.98% |
| Q1 2022 | 7.14% |
| Q4 2021 | 1.28% |
| Q3 2021 | 3.71% |
| Q2 2021 | 59.60% |
| Q1 2021 | -0.10% |
| Q4 2020 | 25.07% |
| Q3 2020 | 274.51% |
| Q2 2020 | -39.86% |
| Q1 2020 | 15.65% |
| Q4 2019 | 172.14% |
| Q3 2019 | 27.54% |
| Q2 2019 | 32.11% |
| Q1 2019 | -2.38% |
| Q4 2018 | 1.20% |
| Q3 2018 | -23.15% |
| Q2 2018 | 90.59% |
| Q1 2018 | -30.18% |
| Q4 2017 | -6.88% |
| Q3 2017 | 19.41% |
| Q2 2017 | -7.79% |
| Q1 2017 | -7.05% |
| Q4 2016 | 7.13% |
| Q3 2016 | 8.16% |
| Q2 2016 | -3.71% |
| Q1 2016 | 5.05% |
| Q4 2015 | 1.63% |